CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 171 enrolled
Drug / intervention
Emervel Classic Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01205048
NCT01205048N/ACompleted

A Pivotal USA Randomized, Evaluator-blinded, Active-controlled, Multi-center, Split-face Comparison Study of Emervel Classic Lidocaine Versus Juvederm® Ultra in the Treatment of Moderate to Severe Facial Wrinkle Folds

Galderma R&D·interventional·Posted Sep 20, 2010·Updated Jul 25, 2023

In Brief

A clinical study evaluating Emervel Classic Lidocaine and Juvederm® Ultra for Skin Wrinkling. Completed, enrolled 171 participants across 12 sites.

Detailed Summary

The purpose of this study is to compare the effectiveness and safety of Emervel Classic Lidocaine versus Juvederm® Ultra in the treatment of moderate to severe facial wrinkles and folds.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Wrinkling
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 20, 2010
Enrollment StartSep 1, 2010
Primary CompletionJun 27, 2011
Study CompletionJan 19, 2012
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 15.8 years ago

Interventions

Emervel Classic Lidocainedevice

20 mg/mL + 0.3% lidocaine

Juvederm® Ultradevice

24mg/mL